Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes
about
Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Recent progress in genetic and epigenetic research on type 2 diabetesNew insights from monogenic diabetes for "common" type 2 diabetesTesting the role of predicted gene knockouts in human anthropometric trait variationThe genetic architecture of type 2 diabetesHuman genetics as a model for target validation: finding new therapies for diabetes.PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.The Genetic Architecture of Diabetes in Pregnancy: Implications for Clinical Practice.Diabetes mellitus: The epidemic of the century.Rare variant association studies: considerations, challenges and opportunities.Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction.PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease.Role of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expression studiesFamily-based approaches: design, imputation, analysis, and beyond.Recent advances in understanding the genetic architecture of type 2 diabetesPerspectives in Polycystic Ovary Syndrome: From Hair to EternityProspective functional classification of all possible missense variants in PPARG.De novo and rare mutations in the HSPA1L heat shock gene associated with inflammatory bowel disease.Imaging mass spectrometry demonstrates age-related decline in human adipose plasticity.Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes.PPARγ mutations, lipodystrophy and diabetes.The genetics of diabetic complications.Mechanisms of Type 2 Diabetes Risk Loci.The Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) in Adipogenesis: Applying Knowledge from the Fish Aquaculture Industry to Biomedical Research.An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.Genome-Wide Studies of Type 2 Diabetes and Lipid Traits in Hispanics.Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes.Complex Genetics of Type 2 Diabetes and Effect Size: What have We Learned from Isolated Populations?When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.The power of multiplexed functional analysis of genetic variants.Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.Epigenomic and transcriptional control of insulin resistance.Distinct but complementary contributions of PPAR isotypes to energy homeostasis.Genetic disorders of nuclear receptors.Systematic Cell-Based Phenotyping of Missense Alleles.Determinants of Power in Gene-Based Burden Testing for Monogenic Disorders.Massively Parallel Genetics.Life after genetics.Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.
P2860
Q26739984-4DA71EBF-CE09-46C3-B981-AC159E48C07AQ26766482-BFCF87CE-4C06-4589-9F51-7B724FEC7107Q26795455-0536C3FF-58B8-45E6-A642-5F0F5C8062ECQ28597672-980E45E9-E82F-445E-94A8-AA51629F82CEQ29583824-36D2014C-AC46-4458-90B2-53D7CB249FEEQ30234640-9B7EA908-FB45-4D78-8DD8-98D585D81129Q30241952-F29ACAFF-EDC2-4C5C-BB8B-C726DF61EAC3Q33898977-55521F7A-43F6-40E8-91DD-8148F69CEEAFQ34671155-970D84F7-6C49-4841-8C54-FA80B4C15513Q35110309-F415AB9E-8843-4432-912F-C2DF39486CD7Q35538234-6DFC263C-6C35-4CA1-AD16-9EA74F7E1FB4Q35632330-D895F1A9-8942-4775-8697-D535762B7891Q35863787-8FC0C337-3F35-4BD6-BEA9-0991C075C574Q35920732-CEC464AD-DA6C-4E64-828A-293F0A5A4A41Q36065329-79E30CFC-3984-468C-9FFE-2328169F851EQ36716040-169F0903-AB60-4102-AD21-6139E8DCE928Q37461625-9A1D775B-FDAA-449D-87F5-C033D566D6B9Q37609709-B06F6EEE-E829-432D-B61E-1B861F636687Q37677435-5EA1ACB4-3753-470B-B483-4B6D67F7CACCQ38264613-19BD8A9C-5AA1-4269-8F7D-07403AF95815Q38280514-E3418437-4CB1-41E6-B960-BDCB6212FECCQ38396875-E03EBA58-4953-4DCF-8D68-0724F659541EQ38652238-CF989E90-B397-4EEA-9F05-E8514E240AADQ38739609-264E0BFD-B390-440D-8A02-E6670262F0D0Q38752732-A3F5DB09-FC95-4C36-BADE-A6A6C2CA8F3CQ38786129-8F3C406B-10EA-4B29-A37E-9141E26483E8Q38808702-2C7A9492-6A43-4201-B43C-DE8F21D398F1Q38816592-F04B3B8F-FED7-4E0C-8F67-CE07A62FC409Q38816600-497C9BCC-ACF2-4524-9AF8-485C2F9506B4Q38825473-45CF9527-D838-4893-82EC-42A749A2AD2FQ38883998-62F4C231-0FBE-4D88-ADEF-3CE430BDC08FQ38980163-2594DB95-B117-491F-9E56-B5E474BD2229Q39214885-1FC6C640-39CC-40F2-9AD1-4B16AAAC9190Q39214888-5231909F-EBD5-4D9E-ABEC-AD052EA8F132Q39282594-FC68AED7-F543-4A15-A5C0-FB1DDF3A39D1Q39469486-46F67726-77D8-45DF-9105-C0D521A410C1Q41813004-02E50E86-0C1F-4F8A-B28D-D167D20E5EB3Q43053932-79767FA5-841A-4762-8755-DA7DED38515DQ45981116-D8D229BA-D007-4BDB-8A67-67B7DE78F03DQ47138654-BF0CFAFF-C8FE-44B1-B8F7-469A0D4119A3
P2860
Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@ast
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@en
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@nl
type
label
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@ast
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@en
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@nl
prefLabel
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@ast
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@en
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@nl
P2093
P2860
P356
P1476
Rare variants in PPARG with de ...... reased risk of type 2 diabetes
@en
P2093
Amit R Majithia
Evan D Rosen
GoT2D Consortium
Jason Flannick
Mark-Anthony Bray
Michael Guo
NHGRI JHS/FHS Allelic Spectrum Project
Peter Shahinian
Pierre Fontanillas
SIGMA T2D Consortium
P2860
P304
13127-13132
P356
10.1073/PNAS.1410428111
P407
P577
2014-08-25T00:00:00Z